When Karen Hsiao Ashe, M.D., Ph.D., talks about her almost 30 years of Alzheimer's disease (AD) research, she always credits the mice.
How else to study this devastating disease of the brain, which gradually robs people of their memories and their ability to complete even the simplest tasks? Mice, so closely linked genetically to humans, offer scientists hope for modeling the disease.
But to study this frustratingly elusive disease in mice, you frst have to create a mouse that gets Alzheimer's disease. And that's no easy feat. effort to conquer this disease, but, she says, four major problems remain to be solved. " We have yet to determine what causes Alzheimer's, and we need to create a more complete mouse model of the disease," she explains. "We also need to discover safe, cheap, and effective drugs for intervention, and, fnally, we need to establish platforms for affordable clinical prevention trials." Again, it's a daunting picture. But Ashe is chipping away. In 2011, she led an effort to create the Twin Cities Consortium for Alzheimer's Research, or T-CAR, a coalition of seven major health care organizations that now share resources and expertise and will ultimately provide a platform for her to reach tens of thousands of people for prevention trials.
Two kinds of support
Ashe has deep gratitude for the philanthropists who have supported her work; she cites Beverly Grossman, who pledged $5 million in 2007 to establish the Grossman Center in honor of her husband, who then was suffering from the disease. He died in 2010.
"The funds are indispensable, yes," says Ashe, "but more than that, Beverly has also given her love and personal encouragement, which has meant so much to me. "Karen is such a forward-looking researcher, so creative in her thinking and, I believe, really on the leading edge of this research," says Moe. "My children and I have seen frsthand how painful this disease can be, how it's caused my husband to become lost from himself. I'm happy I found someone like Karen to support." "Karin is one of my angels," says Ashe. "She gives me her heart, in addition to her funds." Ashe hopes to fnish work on iMouse by 2017 and identify safe and affordable preventive compounds by 2025. "This is hard, time-consuming work," she says, "and in the past it's taken 10 years to answer one question at a time. So, if we work hard, I believe prevention could be within our grasp 10 years from now."
